4//SEC Filing
KURZWEIL RAY 4
Accession 0001562180-25-001842
CIK 0001082554other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:31 PM ET
Size
24.5 KB
Accession
0001562180-25-001842
Insider Transaction Report
Form 4
KURZWEIL RAY
Director
Transactions
- Sale
Common Stock
2025-02-28$318.28/sh−1,303$414,713→ 15,544 total - Sale
Common Stock
2025-02-28$320.43/sh−1,519$486,738→ 14,025 total - Exercise/Conversion
Common Stock
2025-02-28$175.43/sh+15,000$2,631,450→ 27,080 total - Sale
Common Stock
2025-02-28$315.26/sh−4,821$1,519,850→ 20,000 total - Sale
Common Stock
2025-02-28$317.33/sh−897$284,647→ 16,847 total - Sale
Common Stock
2025-02-28$321.53/sh−1,095$352,070→ 12,930 total - Sale
Common Stock
2025-02-28$323.53/sh−100$32,353→ 12,080 total - Exercise/Conversion
Stock Option
2025-02-28−15,000→ 0 totalExercise: $175.43From: 2016-06-26Exp: 2025-06-26→ Common Stock (15,000 underlying) - Sale
Common Stock
2025-02-28$314.25/sh−2,259$709,900→ 24,821 total - Sale
Common Stock
2025-02-28$316.07/sh−2,256$713,060→ 17,744 total - Sale
Common Stock
2025-02-28$322.43/sh−750$241,821→ 12,180 total
Footnotes (9)
- [F1]This transaction was executed in multiple trades at prices ranging from $313.71 USD to $314.69 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $314.71 USD to $315.70 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $315.71 USD to $316.575 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $316.81 USD to $317.78 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $317.84 USD to $318.705 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $320.02 USD to $321.015 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]This transaction was executed in multiple trades at prices ranging from $321.02 USD to $322.00 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F8]This transaction was executed in multiple trades at prices ranging from $322.03 USD to $322.85 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F9]This transaction was executed in multiple trades at prices ranging from $323.46 USD to $323.58 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001108501
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:31 PM ET
- Size
- 24.5 KB